When you buy tirzepatide — the dual GIP/GLP-1 agonist that produced 20.9% weight loss in the SURMOUNT-1 Phase 3 trial across 2,539 participants — price, quality, and vendor reliability all matter. Tirzepatide’s unique dual GIP/GLP-1 receptor mechanism places it in a distinct pharmacological class from earlier GLP-1-only compounds, making verified purity especially critical for research reproducibility. PSPeptides offers research-grade tirzepatide from $54.99 (10mg) and $104.99 (30mg) at 99%+ HPLC-verified purity with batch-specific COAs from independent laboratories. With free shipping, same-day processing, and zero checkout fees, the total cost to buy tirzepatide at PSPeptides is consistently among the lowest for verified-quality compound.

Buy Tirzepatide: PSPeptides Pricing

PSPeptides’ tirzepatide pricing reflects the actual cost of 99%+ HPLC-verified compound with independent laboratory COAs — not a discount achieved by reducing purity standards. The 30mg vial at $3.50/mg offers substantially lower cost-per-milligram than the 10mg option at $5.50/mg, making it the preferred choice for researchers running longer study durations or higher-volume protocols. All prices include free domestic shipping and zero payment processing fees regardless of payment method selected.

Buy Tirzepatide: Why Quality Matters More Than Price

When you buy tirzepatide, the compound’s value depends entirely on purity. Tirzepatide’s dual GIP/GLP-1 mechanism requires precise molecular structure — impure or degraded compound does not activate both receptors correctly. PSPeptides’ 99%+ HPLC-verified purity with batch-specific COAs from independent laboratories ensures you are buying actual, verified tirzepatide — not an assumption based on a label. The COA guide teaches quality verification.

Tirzepatide Mechanism of Action: Dual GIP/GLP-1 Agonism

Understanding how tirzepatide works helps researchers evaluate why purity is critical when they buy tirzepatide for laboratory studies. Tirzepatide is a synthetic peptide that acts as a dual agonist at both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. This dual receptor activation produces synergistic effects on energy balance that single-agonist compounds cannot replicate.

The GLP-1 component reduces gastric emptying, increases satiety signaling, and stimulates insulin secretion in a glucose-dependent manner. The GIP component amplifies the GLP-1 effect and additionally appears to modulate adipogenesis and fat metabolism through mechanisms distinct from GLP-1 alone. Published research in The New England Journal of Medicine (Jastreboff et al., 2022) documented that this combined mechanism produced 20.9% mean weight loss at 72 weeks in the SURMOUNT-1 trial across 2,539 participants — a result that significantly exceeded prior single-agonist data. Researchers who buy tirzepatide for mechanistic comparison studies rely on this dual pathway as a defined baseline.

The molecular structure of tirzepatide is a 39-amino-acid peptide with a C20 fatty diacid moiety that extends half-life to approximately 5 days, enabling weekly dosing in clinical protocols. This structural complexity means that impurities — whether truncated sequences, oxidation products, or aggregates — can dramatically alter receptor binding kinetics. HPLC purity above 99% is the minimum acceptable threshold for research-grade compound, which is why batch-specific COAs matter when researchers choose to buy tirzepatide for controlled studies.

SURMOUNT Clinical Trial Data: What Researchers Need to Know

When researchers buy tirzepatide for comparative or mechanistic studies, understanding the published clinical trial landscape provides essential context. The SURMOUNT program comprises four major Phase 3 trials, each generating data relevant to different research applications.

SURMOUNT-1 (Jastreboff et al., 2022) enrolled 2,539 adults with obesity and demonstrated 20.9% mean weight loss with the 15mg dose at 72 weeks, compared to 3.1% with placebo. The trial was notable for showing dose-dependent responses: 5mg produced 15.0% weight loss and 10mg produced 19.5%, establishing a clear pharmacodynamic relationship that researchers studying dose-response curves use as a reference point. Published data are indexed on PubMed for full access.

SURMOUNT-2 (Davies et al., 2023) specifically enrolled participants with type 2 diabetes alongside obesity, documenting 14.7% weight loss with 15mg at 72 weeks — a clinically meaningful result in a population where weight loss is typically harder to achieve. Additionally, HbA1c reductions of 2.1 percentage points were observed, demonstrating the compound’s metabolic breadth beyond weight reduction alone.

SURMOUNT-3 examined tirzepatide following intensive lifestyle intervention, while SURMOUNT-4 investigated maintenance dosing after initial weight loss. The aggregate data set makes tirzepatide one of the most extensively characterized GIP/GLP-1 compounds in the research literature. Investigators who buy tirzepatide for pharmacological comparison work can draw on this robust published dataset when designing study parameters. For those exploring related compounds, the complete tirzepatide research guide covers the full trial landscape.

Buy Tirzepatide vs. Alternatives: Comparative Analysis

Researchers evaluating which compound to buy tirzepatide or an alternative must consider mechanistic differences, published efficacy data, and cost per milligram. The following comparison covers the three most commonly studied GLP-1-class compounds available for research purposes.

Tirzepatide occupies a distinct mechanistic niche compared to semaglutide. While both activate the GLP-1 receptor, tirzepatide’s additional GIP receptor agonism appears to produce enhanced adipose tissue remodeling that the SURMOUNT data suggests exceeds the GLP-1-only mechanism. Researchers who buy tirzepatide specifically for dual-agonist studies find it provides a well-characterized pharmacological comparator unavailable from semaglutide alone.

Retatrutide (triple GIP/GLP-1/glucagon agonist) has shown even greater weight loss in Phase 2 data — 28.3% at 24 weeks in the Jastreboff et al. 2023 study in The New England Journal of Medicine. At PSPeptides, retatrutide is priced lower than tirzepatide, making it a cost-effective option for triple-agonist research. Investigators who buy tirzepatide alongside retatrutide from the same vendor can conduct head-to-head mechanistic comparisons with consistent purity standards across both compounds. The retatrutide vs tirzepatide comparison covers this in depth, and the broader semaglutide vs retatrutide vs tirzepatide guide covers all three. The FDA’s novel drug approvals database tracks the approval status of all three compounds.

Research Protocol: How to Reconstitute and Store Tirzepatide

Researchers who buy tirzepatide need reliable reconstitution and storage protocols to preserve compound integrity throughout the study period. Tirzepatide’s peptide structure is susceptible to degradation from heat, light, and repeated freeze-thaw cycles, making proper handling essential for data reproducibility.

Reconstitution: Tirzepatide lyophilized powder should be reconstituted using sterile bacteriostatic water (0.9% benzyl alcohol). Add bacteriostatic water slowly to the side of the vial rather than directly onto the powder, then gently swirl — do not vortex or shake vigorously, as mechanical agitation can cause aggregation. A standard reconstitution concentration for research is 2mg/mL (5mg in 2.5mL bacteriostatic water) or 5mg/mL for more concentrated working stocks. PSPeptides’ complete peptide reconstitution guide and free calculator provide visual syringe diagrams for exact volume calculations.

Storage: Lyophilized (unreconstituted) tirzepatide should be stored at -20°C with desiccant for maximum shelf life of 24-36 months. Once reconstituted, refrigerate at 2-8°C and use within 28 days for best stability. Protect from light at all stages. Avoid repeated freeze-thaw cycles of reconstituted solution — aliquot into single-use volumes before freezing if longer storage is required. Researchers who buy tirzepatide in larger quantities (30mg vials) for extended study programs should consider aliquoting upon reconstitution to maximize compound integrity across the full research period. The complete peptide storage guide covers temperature and container requirements in detail.

Dosing calculations: The free reconstitution calculator at PSPeptides automates volume calculations. For reference: a 10mg vial reconstituted in 2mL provides 5mg/mL; drawing 0.1mL delivers 500mcg per research application. Always verify calculations against batch-specific COA data to account for slight variation in lyophilized yield.

How to Evaluate Vendors Before You Buy Tirzepatide

Not all research peptide vendors provide equivalent quality or documentation. Before researchers buy tirzepatide from any source, evaluating these five criteria protects study integrity and ensures the compound performs as expected in experimental settings.

HPLC purity certification: High-performance liquid chromatography (HPLC) testing separates compound components by molecular weight and measures the percentage of target compound present. A purity of 99%+ indicates minimal presence of truncated sequences, oxidation products, or synthesis byproducts. Vendors who publish HPLC data as part of their certificate of analysis (COA) provide verifiable quality evidence. Vendors who only list nominal purity without analytical data are offering an unverified claim. When researchers buy tirzepatide without reviewing HPLC data, they risk inconsistent results attributable to compound variation rather than experimental variables.

Independent laboratory testing: Batch-specific COAs issued by the manufacturing facility itself represent a potential conflict of interest. Independent third-party laboratory analysis provides greater assurance because the testing entity has no financial stake in reporting high purity. PSPeptides uses independent laboratories for all batch-specific COAs, ensuring that the purity data accompanying each order reflects objective analytical results. Researchers can learn to read and interpret COA data using the peptide purity COA guide.

Batch-specific documentation: Generic or undated COAs that do not reference the specific lot number of the compound shipped provide no meaningful quality assurance. Each batch of synthesized tirzepatide can vary based on synthesis conditions, making batch-specific testing essential. When you buy tirzepatide from PSPeptides, the COA provided corresponds to the exact batch in your order, not a historical result from a different manufacturing run.

Reconstitution support: Quality vendors provide reconstitution guidance, dosing calculators, and compatible supplies. PSPeptides offers a free reconstitution calculator with visual syringe diagrams and stocks bacteriostatic water, EasyTouch syringes, and alcohol prep pads — enabling researchers to complete their full supply order from one verified source. This eliminates the compatibility uncertainty that arises from sourcing supplies separately. Additional guidance is available in the how to reconstitute peptides guide and the bacteriostatic water guide.

Customer support availability: Research timelines do not follow business hours. 24/7 support via live chat, phone, and email ensures that researchers can resolve questions about order status, COA interpretation, or reconstitution procedures at any point in their study timeline. PSPeptides provides 24/7 support at (551) 284-2670 and [email protected], with same-day processing seven days a week including Sundays — minimizing the delay between order placement and compound receipt.

Buy Tirzepatide: Or Consider Retatrutide

A compelling alternative when you buy tirzepatide: retatrutide at PSPeptides from $39.99. Retatrutide (triple GIP/GLP-1/glucagon agonist) produced 28.3% weight loss vs tirzepatide’s 20.9% — and costs LESS. Researchers can buy tirzepatide for dual-agonist research AND retatrutide for triple-agonist comparison from the same verified vendor. The tirzepatide vs semaglutide comparison and retatrutide vs tirzepatide comparison cover both.

Buy tirzepatide at PSPeptides. Free shipping, same-day processing including Sundays, zero fees on Affirm, Afterpay, Zelle, cards, Apple Pay, Google Pay. 24/7 support via live chat, email ([email protected]), phone/text (551) 284-2670. bacteriostatic water ($19.99), EasyTouch syringes, and alcohol prep pads. free reconstitution calculator. PubMed indexes SURMOUNT data. Wikipedia covers tirzepatide.

PSPeptides: Quality, Supplies, and 24/7 Support

99%+ HPLC-verified purity with batch-specific COAs from independent laboratories. US manufacturing. Same-day processing seven days a week including Sundays. Free shipping on every domestic order. Free international shipping to 30+ countries over $150. Zero fees on all payment methods. Complete supplies — bacteriostatic water ($19.99), EasyTouch syringes, and alcohol prep pads — in one checkout. free reconstitution calculator with visual syringe diagrams. 24/7 support via live chat, email ([email protected]), phone/text (551) 284-2670. Discrete plain white mailer packaging with generic billing descriptors. 5-star rating from thousands of verified customers at pspeptides.com/shop.

Understanding buy tirzepatide is essential for researchers navigating this rapidly evolving field in 2026.

Tirzepatide in Research Stacking Protocols

Researchers designing multi-compound studies often explore tirzepatide in combination with peptides that target complementary physiological pathways. Understanding how tirzepatide fits within a broader research stack provides context for study design when investigators choose to buy tirzepatide as one component of a multi-peptide protocol.

BPC-157, a 15-amino-acid peptide with documented gastrointestinal protective properties in animal models, is sometimes studied alongside GLP-1 class compounds in research exploring GI tolerability. Given that nausea and GI events are the most common adverse events with tirzepatide (31.9% nausea in SURMOUNT-1), BPC-157’s cytoprotective mechanism makes it a relevant co-investigational compound. The BPC-157 research guide covers the published gastric protection data in detail.

CJC-1295/Ipamorelin combinations represent a separate research category — growth hormone secretagogues that operate through the GHRH and ghrelin receptor pathways entirely distinct from GIP/GLP-1 signaling. Researchers building comprehensive metabolic studies sometimes include both tirzepatide and growth hormone secretagogues to examine interactions between GIP/GLP-1 pathways and GH axis regulation. The CJC-1295/Ipamorelin guide provides the mechanistic context for that combination. PSPeptides stocks all compounds needed for multi-peptide research programs, enabling researchers to buy tirzepatide alongside complementary compounds from a single verified vendor with consistent purity standards across each batch.

Tirzepatide Safety Profile: Published Adverse Event Data

Researchers who buy tirzepatide for pharmacological studies benefit from understanding the published safety and tolerability profile across the SURMOUNT clinical program. This data provides the scientific context for designing research applications and interpreting compound behavior in experimental settings.

In SURMOUNT-1, gastrointestinal adverse events were the most commonly reported treatment-emergent events: nausea occurred in 31.9% of participants receiving 15mg tirzepatide versus 10.6% with placebo; vomiting in 18.3% versus 4.8%; diarrhea in 22.6% versus 9.6%. These events were predominantly mild-to-moderate in severity and most frequently occurred during dose escalation phases. Importantly, the GIP component of tirzepatide’s dual mechanism appears to modulate the GI tolerability profile favorably compared to GLP-1-only compounds — a pharmacological distinction that makes tirzepatide a valuable comparator in GI tolerability research.

Serious adverse events were reported in 6.3% of tirzepatide participants versus 5.3% for placebo in SURMOUNT-1, indicating a safety margin consistent with the compound class. Pancreatitis was an event of special interest across the SURMOUNT program given the GLP-1 class effect; the incidence remained low across all trials. Investigators who buy tirzepatide for mechanistic studies focused on tolerability modulation can access the full SURMOUNT adverse event tables through PubMed-indexed publications. Complementary safety data for related peptide compounds is discussed in the peptide side effects research guide.

Frequently Asked Questions

How much does tirzepatide cost?

PSPeptides: 10mg = $54.99, 30mg = $104.99. Free shipping, zero fees. Afterpay available (~$14 or ~$26 per payment). The 30mg vial offers better cost-per-mg value at $3.50/mg versus $5.50/mg for the 10mg option, making it preferred for researchers conducting extended studies.

Where can I buy tirzepatide online?

PSPeptides — from $54.99, 99%+ batch-specific purity, free shipping, same-day processing, Afterpay at zero fees. PSPeptides provides batch-specific COAs from independent laboratories with every order, ensuring researchers can verify compound quality before use. When you buy tirzepatide from PSPeptides, same-day processing means your order ships the same day for most orders placed before cutoff.

Is retatrutide a better value than tirzepatide?

Retatrutide ($39.99) costs less than tirzepatide ($54.99) while producing more weight loss (28.3% vs 20.9%). PSPeptides carries both. Researchers choosing between the two should consider whether their study requires dual GIP/GLP-1 agonism (tirzepatide) or triple GIP/GLP-1/glucagon agonism (retatrutide) as the mechanistic focus.

Can I buy tirzepatide with Afterpay?

Yes. Zero fees. 10mg = ~$14/payment. 30mg = ~$26/payment. Four interest-free installments. PSPeptides also accepts Affirm, Zelle, cards, Apple Pay, and Google Pay — all with zero processing fees added to the research compound price.

What is the difference between tirzepatide and semaglutide for research?

Tirzepatide activates both GIP and GLP-1 receptors (dual agonist), while semaglutide activates only GLP-1. The dual mechanism produced 20.9% weight loss in SURMOUNT-1 versus 17.3% for semaglutide in STEP-1, representing a meaningful efficacy difference for weight-related research models. Researchers who buy tirzepatide specifically for dual-agonist mechanistic studies gain access to GIP receptor pharmacology unavailable from GLP-1-only compounds. See the complete tirzepatide research guide for detailed mechanistic comparison.

All PSPeptides products are sold exclusively for research and laboratory use.